Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 125.00K | $ 125.00K |
| Gross Profit | $ 0.00 | $ -990.00K | $ -23.98M | $ 125.00K | $ -14.47M |
| Operating Income | $ -48.27M | $ -33.37M | $ -38.39M | $ -34.72M | $ -25.73M |
| EBITDA | $ -48.27M | $ -52.10M | $ -37.43M | $ -16.31M | $ -25.49M |
| Net Income | $ 0.00 | $ -55.18M | $ -37.94M | $ -18.79M | $ -36.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 119.73M | $ 102.65M | $ 35.41M | $ 70.06M | $ 82.64M |
| Total Assets | $ 125.19M | $ 106.87M | $ 41.20M | $ 78.52M | $ 89.20M |
| Total Debt | $ 1.90M | $ 13.47M | $ 22.76M | $ 22.80M | $ 560.00K |
| Net Debt | $ -117.83M | $ -89.18M | $ -12.65M | $ -47.26M | $ -82.08M |
| Total Liabilities | $ 73.27M | $ 40.54M | $ 28.46M | $ 30.80M | $ 25.07M |
| Stockholders' Equity | $ 51.92M | $ 66.33M | $ 12.74M | $ 47.71M | $ 64.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -38.90M | $ -27.04M | $ -34.70M | $ -32.72M | $ -24.05M |
| Operating Cash Flow | $ -38.31M | $ -27.02M | $ -34.24M | $ -31.42M | $ -22.22M |
| Investing Cash Flow | $ -560.00K | $ -16.00K | $ -280.00K | $ -1.30M | $ -1.83M |
| Financing Cash Flow | $ 56.10M | $ 94.28M | $ -121.00K | $ 19.97M | $ 71.80M |